LONG-TERM EFFICACY OF A NEW FORMULATION OF PROSTAGLANDIN-E1 AS TREATMENT FOR ERECTILE FAILURE

Citation
M. Godschalk et al., LONG-TERM EFFICACY OF A NEW FORMULATION OF PROSTAGLANDIN-E1 AS TREATMENT FOR ERECTILE FAILURE, The Journal of urology, 155(3), 1996, pp. 915-917
Citations number
10
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
00225347
Volume
155
Issue
3
Year of publication
1996
Pages
915 - 917
Database
ISI
SICI code
0022-5347(1996)155:3<915:LEOANF>2.0.ZU;2-8
Abstract
Purpose: We determined the long-term efficacy of intracavernous inject ion of a new formulation of prostaglandin E1 (Caverject) as treatment for erectile failure. Materials and Methods: A prospective study was done at a university affiliated Veterans Affairs medical center. Subje cts with erectile failure received injections of prostaglandin E1 at t he office and self-administered injections at home for up to 18 months . Results: Of 16 patients who performed home injections 15 completed 6 months and 10 completed 18 months of therapy. Patient and spousal sat isfaction with intercourse was 90% for months 1 to 6, and patient sati sfaction was 95% for months 7 to 18. Conclusions: Prostaglandin E1 was highly effective at producing penile rigidity and an erection with sa tisfactory vaginal intercourse.